The purpose of this paper is to provide an integrative review and offer novel insights
regarding human research with classic psychedelics (classic hallucinogens), which are …

Various forms of self-loss have been described as aspects of mental illness (eg,
depersonalization disorder), but might self-loss also be related to mental health? In this …

Psilocybin can occasion mystical-type experiences with participant-attributed increases in
well-being. However, little research has examined enduring changes in traits. This study …

Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically
relevant effects in alcohol and drug addiction. Although recent studies have investigated the …

Awe is a complex emotion composed of an appraisal of vastness and a need for
accommodation. The purpose of this study was to develop a robust state measure of awe …

Despite suggestive early findings on the therapeutic use of hallucinogens in the treatment of
substance use disorders, rigorous follow-up has not been conducted. To determine the …

The 30-item revised Mystical Experience Questionnaire (MEQ30) was previously developed
within an online survey of mystical-type experiences occasioned by psilocybin-containing …

The phenomenon of 'microdosing', that is, regular ingestion of very small quantities of
psychedelic substances, has seen a rapid explosion of popularity in recent years …

Psilocybin-occasioned mystical experiences have been linked to persisting effects in healthy
volunteers including positive changes in behavior, attitudes, and values, and increases in …

This chapter begins with a brief review of descriptions and definitions of mystical-type
experiences and the historical connection between classic hallucinogens and mystical …